Aptus Capital Advisors LLC Has $1.14 Million Position in The Clorox Company $CLX

Key Points

• Aptus Capital Advisors LLC increased its holdings in Clorox by 56.5% in Q1, now owning 7,721 shares valued at approximately $1.14 million.
• Clorox recently announced a quarterly dividend increase to $1.24 per share, yielding 4.1%, with a dividend payout ratio of 76.07%.
• The company's earnings per share for the last quarter were $2.87, surpassing expectations, and Clorox has set its FY 2026 guidance at $5.95-$6.30 EPS.

Aptus Capital Advisors LLC raised its stake in The Clorox Company (NYSE:CLX - Free Report) by 56.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,721 shares of the company's stock after acquiring an additional 2,788 shares during the period. Aptus Capital Advisors LLC's holdings in Clorox were worth $1,137,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Wood Tarver Financial Group LLC acquired a new stake in Clorox during the 4th quarter valued at $31,000. GW&K Investment Management LLC boosted its holdings in Clorox by 239.1% during the first quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock valued at $43,000 after acquiring an additional 208 shares during the period. Roble Belko & Company Inc boosted its holdings in Clorox by 140.7% during the first quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock valued at $53,000 after acquiring an additional 211 shares during the period. IMA Advisory Services Inc. acquired a new position in shares of Clorox during the first quarter valued at about $58,000. Finally, Menard Financial Group LLC acquired a new position in shares of Clorox during the fourth quarter valued at about $63,000. Institutional investors own 78.53% of the company's stock.

Clorox Trading Down 0.7%

CLX stock traded down $0.82 during midday trading on Monday, reaching $119.49. The company's stock had a trading volume of 1,814,588 shares, compared to its average volume of 1,640,658. The business's 50-day simple moving average is $124.25 and its 200-day simple moving average is $135.22. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The stock has a market cap of $14.61 billion, a PE ratio of 18.33, a price-to-earnings-growth ratio of 0.96 and a beta of 0.49. The Clorox Company has a 52 week low of $117.35 and a 52 week high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period last year, the business posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th will be issued a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.2%. This is a boost from Clorox's previous quarterly dividend of $1.22. The ex-dividend date is Wednesday, August 13th. Clorox's dividend payout ratio (DPR) is 76.07%.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Evercore ISI set a $140.00 price target on shares of Clorox and gave the stock an "underperform" rating in a research report on Tuesday, May 6th. Wells Fargo & Company increased their price target on shares of Clorox from $135.00 to $138.00 and gave the stock an "equal weight" rating in a research report on Friday, August 1st. Morgan Stanley dropped their price target on shares of Clorox from $150.00 to $137.00 and set an "equal weight" rating for the company in a research report on Friday, August 1st. JPMorgan Chase & Co. dropped their price target on shares of Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a research report on Friday, July 25th. Finally, UBS Group dropped their price target on shares of Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a research report on Thursday, July 17th. One research analyst has rated the stock with a Buy rating, eight have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Reduce" and an average target price of $143.36.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.